Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


Pluristem Therapeutics’ Cell Therapy Broadens Addressable Markets - Demonstrates Systemic Effectiveness of Intramuscular Delivery 

 

 

Pluristem Therapeutics’ Cell Therapy Broadens Addressable Markets - Demonstrates Systemic Effectiveness of Intramuscular Delivery

 

June 19, 2012 - (Pluristem) - "Pluristem Therapeutics, Inc. announced today at the 2012 Bio International Convention the results of a pre clinical study it conducted measuring the effectiveness of its Placental eXpanded (PLX) cells when administered intramuscularly(IM). Cell therapies are traditionally delivered through intravenous (IV) injections for systemic effect. However, Pluristems’ latest findings show that its PLX cells can be effective when injected by needle, into the muscle. Avoiding the use of an IV is simple and more cost-effective."  Read Full Article

 

 

Posted on 2-Jul-12 by Toto, Brent
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: